Recent YSCC Discoveries
Katerina Politi, PhD, Professor of Pathology; Co-Leader, Cancer Signaling Networks; and Scientific Director for the Center for Thoracic Cancers, is one of five individuals newly elected to the American Association for Cancer Research (AACR) Board of Directors.
- March 12, 2024
The newly announced election brings the number of AAP members from Yale to 53.
- March 11, 2024
As a part of our “Meet Yale Internal Medicine” series, today’s feature is on Romina Fiorotto, PhD, assistant professor (digestive diseases and pathology).
- March 11, 2024
Janice Crabtree has been honored with the 2024 Donna Wachter Clerkship Coordinator Award through the Association of Professors of Gynecology and Obstetrics [APGO].
- March 11, 2024
The National Institutes of Health (NIH) recently awarded Yibing Qyang, PhD, and his colleagues a $2+ million R01 grant to support research to create an artificial blood vessel that can grow, pump, and resist infection and clotting.
- February 28, 2024
The Marcus Foundation has awarded $13.2 million to Yale School of Medicine, to support a clinical trial that could mark a first step toward a preventive treatment for Parkinson's disease.
- February 28, 2024
Yale Cancer Center has a long history of breakthrough cancer research and is perhaps best known as the institution where cancer chemotherapy and the entire field of cancer drug development was discovered and the very first cancer drug was administered in 1942. Dr. William Gardner's studies on steroid hormones and their role in experimental carcinogenesis added another dimension to our understanding of malignant disease. The first FDA approved selective immunotherapy treatment for any type of cancer, Transimmunization, was also developed at Yale under the direction of Dr. Richard Edelson.
- February 28, 2024
Institutional support, federal funding, philanthropy and grants are the support that make cancer research possible.
- February 26, 2024
Elise Liu, MD, PhD, instructor of medicine (rheumatology, allergy and immunology) at Yale School of Medicine, was named a recipient of a 2024 American Academy of Allergy, Asthma and Immunology (AAAAI) Foundation Faculty Development Award.
- February 26, 2024
Fourteen members of the Yale School of Medicine (YSM) and Yale School of Public Health (YSPH) faculties have been elected to the Connecticut Academy of Science and Engineering (CASE). In all, 35 of Connecticut’s leading experts in science, technology, engineering, mathematics, and medicine were elected this year.